Cyclooxygenase-2 in transitional cell carcinoma--a legitimate target?
Adam
Rosalyn
R
D002295:Carcinoma, Transitional Cell / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D051546:Cyclooxygenase 2 / Q000502:physiology*; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology
D052246:Cyclooxygenase 2 Inhibitors; D051546:Cyclooxygenase 2